Mayo Clinic Mayo Clinic Laboratories, Helix Collaborate to Offer Biopharma Lab Services The partnership makes Mayo's tests and pathology services and Helix's Exome+ assay available to biopharma customers. Team Untangles Mechanism Behind Noncoding Glioma Risk Variant A SNP on chromosome 8 that increases risk of IDH-mutant low-grade glioma falls in a brain-specific enhancer that alters transcription factor binding and downstream signaling. Genomadix, Mayo Clinic Collaborate on Point-of-Care PCR The deal is intended to advance the firm's portable PCR-based diagnostics system, called the Cube, which generates results in approximately one hour. Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change Premium Several institutions, swayed by PGx experts and advocates, are setting up DPYD testing to avoid deadly chemo toxicities in patients even though the NCCN and FDA don't back it. Biotia Joins Mayo Clinic Program for AI Startups The firm will focus on validating its next-generation sequencing-based microbial surveillance service and readying it for clinical use. Jun 6, 2022 UK Team Tests Whole-Genome, Targeted Sequencing in Family Practice Setting May 19, 2022 Medical Genome Initiative Develops Best Practices, Standards for Clinical Whole-Genome Sequencing Premium Apr 29, 2022 In Brief This Week: Natera, Caris Life Sciences, Fulgent Genetics, Castle Biosciences, More Apr 13, 2022 Mayo Clinic Study Bolsters Implementation of PGx Data in Clinical Practice Premium Apr 11, 2022 Cancer Genomics Project in Southwestern American Indians Aims to Improve Research, Care Disparities Mar 30, 2022 Prostate Cancer Analysis Explores Age-Related Risk Linked to Polygenic Risk Score Oct 27, 2021 TripleBlind Promises to Bring Data Encryption Technology to Life Sciences Premium Oct 13, 2021 Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration May 4, 2021 Phenomix, Mayo Clinic Ink Licensing Deal for Obesity Phenotype Blood Test Feb 24, 2021 WuXi Diagnostics Closes $150M Series B Financing Round Feb 19, 2021 BRCA2 Variants of Unknown Significance Reclassified Through Functional Data Additions Feb 18, 2021 Stella Diagnostics, Mayo Clinic Collaborating on Barrett's Esophagus Protein Markers Feb 11, 2021 Cue Health Ramping Up COVID-19 Test Production Following Positive Mayo Clinic Study, DoD Funding Premium Jan 21, 2021 Breast Cancer Risk Gene Associations Refined in Large-Scale Studies Dec 15, 2020 Life Sciences Software Company Nference Completes $60M Series C Funding Round Nov 19, 2020 Putting Expanded Carrier Screening Into Practice Requires Considerations to Avoid Pitfalls Premium Oct 30, 2020 Broad Genetic Testing Uncovers Additional Risk Variants in Cancer Patients, Study Finds Sep 15, 2020 Pancreatic Cancer Treatment Clues Uncovered From Genomic, Chromatin Profiles Sep 10, 2020 Longitudinal Irritable Bowel Syndrome Omics Study Points to Possible Treatment Target Aug 25, 2020 Trial Shows Some Benefit of Genetically Guided Antiplatelet Therapy After Balloon Angioplasty Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.